Back to calendar
Avalo Therapeutics, Inc. (AVTX) Earnings
AVTX reports earnings on Thursday, August 6, 2026
earnings report
August 6, 2026
Q2 2026
Est. EPS: $-0.53
Actual EPS: $-0.83
EPS surprise: -42.43%
Company overview
Market Cap$969.2M
PriceUSD 18.32
EPS (TTM)-4.74
52-week high24.27
52-week low8.29
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees33